September 27 - October 01, 2013; Amsterdam, the Netherlands
This coverage is not sanctioned by, nor a part of the European Cancer Organization, the European Society for Medical Oncology, or the European Society for Radiation and Oncology.
Medscape Oncology© WebMD, LLC
Oncologists Initiate Upgrade of European Cancer Care
Prostate Cancer: Enough 'Me Too’ Drugs
Bevacizumab: Mixed Results in Glioblastoma
Ipilimumab Goes the Distance in Melanoma Survival
New ALK Agents: Lung Cancer's 'Second Miracle'?
TDM-1 Heavy Hitter in Heavily Treated Breast Cancer